WallStSmart

eHealth Inc (EHTH)vsMarsh & McLennan Companies Inc (MMC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies Inc generates 4675% more annual revenue ($26.45B vs $554.01M). MMC leads profitability with a 15.6% profit margin vs 7.2%. EHTH appears more attractively valued with a PEG of 0.72. MMC earns a higher WallStSmart Score of 62/100 (C+).

EHTH

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 6.0Value: 6.7Quality: 5.0

MMC

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 7.3Quality: 4.8
Piotroski: 3/9Altman Z: 1.67
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EHTH.

MMCSignificantly Overvalued (-222.6%)

Margin of Safety

-222.6%

Fair Value

$56.64

Current Price

$182.70

$126.06 premium

UndervaluedFair: $56.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHTH3 strengths · Avg: 9.3/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Operating MarginProfitability
38.7%10/10

Strong operational efficiency at 38.7%

PEG RatioValuation
0.728/10

Growing faster than its price suggests

MMC3 strengths · Avg: 8.7/10
Market CapQuality
$89.82B9/10

Large-cap with strong market position

Return on EquityProfitability
28.7%9/10

Every $100 of equity generates 29 in profit

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

EHTH4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.5%4/10

3.5% revenue growth

Market CapQuality
$45.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.2%3/10

ROE of 4.2% — below average capital efficiency

Profit MarginProfitability
7.2%3/10

7.2% margin — thin

MMC4 concerns · Avg: 3.8/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.674/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : EHTH

The strongest argument for EHTH centers on Price/Book, Operating Margin, PEG Ratio. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bull Case : MMC

The strongest argument for MMC centers on Market Cap, Return on Equity, Free Cash Flow. Profitability is solid with margins at 15.6% and operating margin at 19.2%. Revenue growth of 11.5% demonstrates continued momentum.

Bear Case : EHTH

The primary concerns for EHTH are Revenue Growth, Market Cap, Return on Equity.

Bear Case : MMC

The primary concerns for MMC are PEG Ratio, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

EHTH profiles as a value stock while MMC is a mature play — different risk/reward profiles.

EHTH carries more volatility with a beta of 1.20 — expect wider price swings.

MMC is growing revenue faster at 11.5% — sustainability is the question.

MMC generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

EHTH scores higher overall (62/100 vs 62/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

eHealth Inc

FINANCIAL SERVICES · INSURANCE BROKERS · USA

eHealth, Inc. provides private health insurance exchange services to individuals, families, and small businesses in the United States and China. The company is headquartered in Santa Clara, California.

Marsh & McLennan Companies Inc

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh McLennan (formerly known as Marsh & McLennan Companies) is a global professional services firm, headquartered in New York City with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, Guy Carpenter, Mercer, and Oliver Wyman.

Want to dig deeper into these stocks?